Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company pioneering targeted antitumor virotherapies, announced today that the U.S. Food and Drug ...

We are thrilled to welcome Chris to our team at this exciting time for Design, as we advance our portfolio of GeneTAC ® small molecules toward key clinical milestones,” said Pratik Shah, Ph.D., ...

Under Reshma Kewalramani's leadership, Vertex achieved a major milestone with the FDA’s first-ever approval of a CRISPR-based ...

North Carolina is listed as a location for the manufacture of AstraZeneca and Sanofi's respiratory syncytial virus (RSV) prevention antibody, nirsevimab, as well as for GSK's two-drug HIV regimen ...

Fintel reports that on April 14, 2025, TD Cowen downgraded their outlook for ICON Public Limited (NasdaqGS:ICLR) from Buy to Hold. Analyst Price Forecast Suggests 68.84% Upside As of April 2, 2025, ...

This is especially true with the U.S. Drug Enforcement Administration (DEA) moving to reclassify marijuana from a Schedule 1 controlled substance (no accepted medical use and a high potential for ...

President Donald Trump’s offensive against elite universities is also an assault on the nation’s most economically dynamic ...

Ottawa, April 11, 2025 (GLOBE NEWSWIRE) -- According to Precedence Research, the global medical affairs outsourcing market ...

Levi & Korsinsky, LLP notifies investors in ICON Public Limited Company ("ICON " or the "Company") of a class action securities ...

Imperial plans to open its newest Imperial Global hub in India in May 2025. Imperial – ranked second best university in the ...

On April 9, 2025, ICON ... biotechnology companies worldwide. Despite some uncertainty driven by recent personnel changes at ...